Infigratinib, is an anti-cancer medication used to treat cholangiocarcinoma (bile duct cancer). tyrosine kinase inhibitor, FGFR1, FGFR2, FGFR3

Size: 12903px × 5097px
Photo credit: © Sciwriters / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: 872511-34-7, anti-cancer, bgj-398, chemical, factor, fgfr, fgfr1, fgfr2, fgfr3, fibroblast, formula, growth, infigratinib, inhibitor, inhibitors, kinase, medication, receptor, structure, truseltiq, tyrosine